The QualityStocks Daily Wednesday, July 17th, 2019

Today's Top 3 Investment Newsletters

QualityStocks (STMDF) +426.32%

AwesomeStocks (SMPP) +78.18%

MarketBeat (NLS) +35.84%

The QualityStocks Daily Stock List

Bonterra Resources, Inc. (BONXF)

MiningFeeds, Junior Mining Network, Stockwatch, Wall Street Nation, Proactive Investors, Minestat, Stock Junction, Investing News, and Stockhouse reported beforehand on Bonterra Resources, Inc. (BONXF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Bonterra Resources, Inc. is a gold exploration company listed on the OTC Markets’ OTCQX. It has a large balanced portfolio of exploration and mining assets including the Gladiator, Barry and Moroy deposits, Urban-Barry Mill and manifold highly prospective exploration prospects. Incorporated in 2007, Bonterra Resources is headquartered in Val-d'Or, Quebec.

The Company is located in the mining-friendly province of Québec, within the Abitibi Greenstone Belt. Bonterra controls the only permitted gold mill in the region with a large land position of approximately 20,815 hectares in the Urban Barry Camp.

The Urban-Barry Mill is connected to the provincial power grid. It has high-speed Internet and cell phone service with an all-season camp for workers. Bonterra Resources’ plan is to expand the existing mill to 2,400 tonnes per day by the second half of 2019.

The Moroy Deposit is a south-parallel system to the Bachelor mine dipping north towards the Bachelor trend with potential to intersect the main trend at depth. Development and drill programs are taking place at Moroy with greater than 65,000 m of surface and underground drilling completed to date. This year, Bonterra Resources will update the NI 43-101 mineral resource estimate at the Moroy Deposit. In addition, the Company has regional exploration at the Bart Zone, the Coniagas Zone, the Moss Zone, and the St. Cyr Zone.

The Gladiator Deposit is a highly silicified and altered sheared mafic volcanics, locally exhibiting intrusions of syenite and quartz porphyry. Smoky quartz veining also occurs locally containing the bulk of the mineralization and free gold. Mineralization at Bonterra’s Barry Deposit has been identified 1,300 m along strike and 600 m at depth. The deposit remains open in all directions, where a minimum of three distinct sub-parallel gold bearing shear zones and secondary tension veins are mineralized.

Last month, Bonterra Resources announced drill results from the continuing exploration campaign at its 100 percent-owned Gladiator, Moroy and Barry projects. The aim of the present drilling campaign is to step out from known mineralization included in Bonterra’s recently released mineral resource estimate on the three projects. The Company intersected 101.1 g/t Au over 3.9 m at Gladiator and 12.8 g/t Au over 5.6 m at Moroy.

Mr. Greg Gibson, Bonterra Resources’ Chairman and Interim Chief Executive Officer, said, "These recent encouraging drill results bode well for the expansion of the current resource. The Company now has five drill rigs working on the current exploration-drilling program on its three projects with multiple targets currently being tested to expand the gold mineralization footprint."

Last week, Bonterra Resources announced that it filed two technical reports prepared in accordance with National Instrument 43‐101 - Standards of Disclosure for Mineral Projects (NI 43-101); the technical report titled "Technical Report on the Moroy Project - Mineral Resources Estimate, Desmaraiville, Quebec" and, the technical report titled, "Technical Report on the Resource Estimates for the Barry and Gladiator Deposits, Urban Barry Property, East of Lebel-sur-Quévillon, Quebec", both prepared by SGS Canada, Inc., having an effective date of May 6, 2019 and supporting the disclosure made by Bonterra Resources in its May 28, 2019 press release announcing mineral resource estimates for its gold deposits in the Urban Barry Camp, Quebec. Bonterra noted that there are no material differences in the technical reports from the information disclosed in the press release.

Bonterra Resources, Inc. (BONXF), closed Wednesday's trading session at $2.07, up 1.8701%, on 80,693 volume with 106 trades. The average volume for the last 3 months is 47,177 and the stock's 52-week low/high is $0.223000004/$2.86999988.

chart

Intrinsyc Technologies Corporation (ISYRF)

Investorx, TeleTrader, Ceo.ca, Virtual-Strategy.com, PortfolioSharing, PR Newswire, Stockhouse, Stockwatch, Wallet Investor, MarketBeat, InvestorFile, and 4-Traders reported previously on Intrinsyc Technologies Corporation (ISYRF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Intrinsyc Technologies Corporation is a foremost provider of solutions for the development of embedded and Internet of Things (IoT) products. The Company provides comprehensive product development services, and also the industry’s highest-performance edge computing modules, to enable fast commercialization of intelligent IoT products. OTCQX-listed, Intrinsyc Technologies is headquartered in Vancouver, British Columbia.

Fundamentally, Intrinsyc Technologies provides hardware, software, and services that enable next-generation intelligent connected products. Its solutions encompass the entire development life cycle and help device makers and technology suppliers create differentiated products with quicker time-to-market. Intrinsyc offers a portfolio of embedded computing modules based on Snapdragon™ technology from Qualcomm® Technologies, Inc., and i.MX processors from NXP Semiconductors N.V.

Intrinsyc Technologies partners with the world’s top OEMs (original equipment manufacturers) to create award-winning products. These include consumer mobile devices and embedded and IoT applications such as robotics, wearables, automotive, medical, video conferencing, digital signage, industrial and consumer cameras, and many more.

Recently, Intrinsyc Technologies announced the availability of the Open-Q™ 820Pro µSOM (micro System on Module) and Development Kit. The Company's Open-Q™ 820Pro µSOM provides an enhanced power-performance combination from Intrinsyc’s popular 820 µSOM, with increased processing power, more memory, and long-life availability, in the same ultra-compact 25x50 mm form factor.

The production ready, pre-certified 820Pro µSOM is a pin compatible, drop-in replacement for the existing 820 µSOM. It requires only SW changes to provide higher performance, with more efficiency, and long-term availability.

On July 3, 2019, Intrinsyc Technologies announced the receipt of orders, over the past week from that date, which are in total valued at US$818,176. Orders for its Open-Q™ embedded computing modules are valued at US$384,240. They include an initial stocking order for a new production client building medical devices. In addition, Intrinsyc received orders from existing and new clients for product development services valued in total at US$433,936.

Intrinsyc Technologies Corporation (ISYRF), closed Wednesday's trading session at $1.03403, up 17.5168%, on 260 volume with 3 trades. The average volume for the last 3 months is 582 and the stock's 52-week low/high is $0.842499971/$1.30180001.

chart

Sanara MedTech, Inc. (SMTI)

Zacks, StocksNewsFeed, Digital Journal, Investors Hangout, Simply Wall St, TradingView, Investing.com, Stockhouse, InvestorsHub, and Stockwatch reported earlier on Sanara MedTech, Inc. (SMTI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Sanara MedTech, Inc. is a provider of surgical and chronic wound care products dedicated to improving patient outcomes. The Company develops, markets and distributes biotechnology products to physicians, hospitals, clinics, and all post-acute care settings. Sanara concentrates on developing and commercializing products in the areas of skin and wound care, including biofilm management. Biofilm management is an important step in the wound healing process. The Company previously went by the name WNDM Medical, Inc. It changed its name to Sanara MedTech, Inc. in May of this year. OTCQB-listed, Sanara MedTech has its headquarters in Fort Worth, Texas.

The Company’s products sell in the North American advanced wound care and surgical tissue repair markets. Sanara MedTech continues to seek long-term strategic partnerships with an emphasis on products that complement its existing portfolio and provide more effective outcomes at a lower overall cost.

The Company sells and distributes CellerateRX® Surgical Activated Collagen® Adjuvant, HYCOL™ Hydrolyzed Collagen, BIAKŌS™ Antimicrobial Skin & Wound Cleanser, and PULSAR II™ Advanced Wound Irrigation System (AWI™). CellerateRX helps to provide a favorable environment for healing. The Activated Collagen® in CellerateRX® Surgical Powder is changing collagen’s role in the operating room. CellerateRX’s® patented Activated Collagen fragments (CRXα®) are a fraction of the size of the native collagen molecules and particles found in other products. They provide the benefits of collagen to the body.

Yesterday, Sanara MedTech announced that BIAKŌS™ Antimicrobial Skin and Wound Cleanser is now available for distribution. BIAKŌS is a Food and Drug Administration (FDA) cleared and patented composition. It effectively disrupts extracellular polymeric substances to eradicate biofilm microbes.

BIAKŌS is intended for mechanical removal of debris, dirt, foreign materials, and microorganisms from wounds. This includes stage I-IV pressure ulcers, diabetic foot ulcers, post-surgical wounds, first and second-degree burns, and grafted and donor sites.

BIAKŌS is effective in killing free-floating microbes, immature and mature bacterial biofilms, including MRSA and Pseudomonas aeruginosa, and fungal biofilms. BIAKŌS safety studies show that it is non-cytotoxic, non-irritating, and non-sensitizing to healthy skin. It assists in the normal wound healing process.

Sanara MedTech, Inc. (SMTI), closed Wednesday's trading session at $7.01, up 3.0882%, on 1,496 volume with 9 trades. The average volume for the last 3 months is 806 and the stock's 52-week low/high is $2.00/$10.00.

chart

BioXyTran, Inc. (BIXT)

Financial Buzz, Born2Invest, Wall Street Analyzer, Last10k, Proactive Investors, Investors Hangout, TradingView, Stockwatch, Simply Wall St, and Wallet Investor reported previously on BioXyTran, Inc. (BIXT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

BioXyTran, Inc. focuses on developing treatments for stroke and Ischemia. An early stage pharmaceutical enterprise, it concentrates on the development, manufacture, and commercialization of different therapeutic drugs to address hypoxia in humans. Its lead pharmaceutical drug candidate is BXT-25. BioXyTran has its corporate headquarters in Newton, Massachusetts.

BioXyTran has its BXT-25 and BXT-252. The design of both drugs are to oxygenate ischemic (reduced blood flow) regions of the body and could provide sufferers valuable aid. BXT-25’s co-polymer proprietary chemical structure acts as the primary carrier of oxygen, instead of the Red Blood Cell that are blocked by the clot.

BXT-25 construct considerably decreases methemoglobin formation and nitric oxide scavenging, which may contribute to an array of disorders, including renal failure, vasoconstriction, hypertension, myocardial infarction, and related toxicity issues. In addition, BXT-25’s small size, about 1/5,000th that of a red blood cell, enables it to perfuse constricted, ischemic capillaries, which are inaccessible to red blood cells because of clots or other obstructions.

BXT-25, in testing, will be evaluated as a resuscitative agent to treat strokes, particularly during the all-critical first hour following a stroke. The product will also undergo evaluation for its efficacy in treating other brain trauma issues.

The design of the Company’s BXT-252 is to treat chronic wounds resulting from ischemia caused by occlusion of capillaries. BXT-252 has the same modality and physical properties as BXT-25. However, its proprietary co-polymer can improve the healing of pressure and arterial ulcers.

BXT-25 is based on a new molecule designed to reverse hypoxia in the brain. Hypoxic brain injuries such as ischemic strokes, could be treated with BXT-25 through an intravenous injection that quickly allows the drug molecule to travel to the lungs and bind with the oxygen molecules. From the lungs the molecule mimics a red blood cell traveling to the brain. Since the molecule is 5,000 times smaller than red blood cells, it can penetrate the clot and deliver the oxygen to the critical areas in the brain blocked by the clot.

BioXyTran, Inc. (BIXT), closed Wednesday's trading session at $1.15, up 15.00%, on 1,735 volume with 7 trades. The average volume for the last 3 months is 2,426 and the stock's 52-week low/high is $0.059999998/$1.95000004.

chart

Excellon Resources, Inc. (EXLLF)

StreetWise Reports, HotStocked, Resource World, Investorx, Northern Miner, Geology for Investors, Trading View, Proactive Investors, Stockwatch, Stockhouse, Wallet Investor, and InvestorsHub reported previously on Excellon Resources, Inc. (EXLLF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Excellon Resources, Inc. is a silver mining and exploration company listed on the OTC Markets. The Company’s 100 percent-owned Platosa Mine has been Mexico's highest-grade silver mine since production began in 2005. In 1996, Excellon was introduced to the La Platosa Project by Dr. Peter Megaw. Excellon Resources has its corporate headquarters in Toronto, Ontario.

Excellon is focused on optimizing Platosa's cost and production profile and discovering further high-grade silver and carbonate replacement deposit (CRD) mineralization on the Platosa Project. The Company is also focused on epithermal silver mineralization on the 100 percent-owned 45,000 hectare Evolution Property. Furthermore, it is focused on capitalizing on present market conditions by acquiring undervalued projects in the Americas.

The Platosa Mine is in a safe jurisdiction with grid power and national highway runs through the property. It is 5km north of Bermejillo, Durango State, Mexico and is 20,969 hectares.

The Evolution Property is in Miguel Auza, Zacatecas, Mexico. It is situated 220 km from the La Platosa Mine. There is a new exploration prospect on the underexplored northern strike of the legendary Fresnillo silver trend, the most prolific silver belt in the world.

Recently, Excellon Resources reported financial results for the three-month period ended March 31, 2019 . Q1 2019 financial and operational highlights, in comparison to Q1 2018, include Revenue of $5.2 million in Q1 2019 (Q1 2018 – $5.9 million ), with an additional $3.4 million in revenue realized in early Q2 2019 from Q1 production. The Company had production of 522,261 silver equivalent (AgEq) ounces (Q1 2018 – 482,079 AgEq ounces). Initial processing of bulk sample has started on ore from Hecla Mining Company's San Sebastian Mine.

Mr. Brendan Cahill, Excellon Resources’ President and Chief Executive Officer, said, "We had a strong start to the year with the mine and mill performing well, both hitting records in March of 256 tonnes per day mined and over 10,000 tonnes processed, respectively. As noted previously, we ended Q1 with a stockpile of more than 2,800 tonnes of high-grade ore and delivered an additional 1,000 tonnes of concentrate early in Q2, which impacted financial results as approximately $3.4 million in revenue was deferred to Q2 that would normally be reflected in Q1. During the second quarter, we expect daily tonnage to continue at a steady rate and our cost profile to improve considerably."

Excellon Resources, Inc. (EXLLF), closed Wednesday's trading session at $1.01, up 10.8793%, on 171,375 volume with 194 trades. The average volume for the last 3 months is 32,146 and the stock's 52-week low/high is $0.442999988/$1.14999997.

chart

First Acceptance Corporation (FACO)

Zacks, TipRanks, InvestorsHub, Insider Tracking, GlobeNewswire, Stockopedia, OTC Markets, Simply Wall St, Wallet Investor, Stockwatch, Glassdoor, Digital Journal, MacroTends, Research Pool, Investing.com, and Stockhouse reported earlier on First Acceptance Corporation (FACO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

First Acceptance Corporation, via its subsidiaries, operates as a retailer, servicer, and underwriter of non-standard personal automobile insurance and other ancillary products in the U.S. The Company’s insurance operations generate revenue from selling these products in 16 States. At March 31, 2019, First Acceptance leased and operated 350 retail locations and a call center staffed with employee-agents. OTCQX-listed and established in 1969, First Acceptance is based in Nashville, Tennessee.

At present, First Acceptance conducts its insurance servicing and underwriting operations in 14 States and operates only as an insurance agency in two States. In addition, the Company is licensed as an insurance company in 12 States where it does not conduct any business.

Products that First Acceptance offers include Auto Insurance, Motorcycle Insurance, Roadside Assistance, Renters Insurance and Homeowners Insurance. Products offered also include Commercial Insurance, Pet Insurance, Life Insurance, and Travel Insurance.

In May, First Acceptance reported its financial results for the quarter ended March 31, 2019. Income before Income Taxes, for the three months ended March 31, 2019 was $8.3 million, versus Income before Income Taxes of $7.2 million for the three months ended March 31, 2018. Net Income for the three months ended March 31, 2019 was $6.5 million, versus Net Income of $5.4 million for the three months ended March 31, 2018. Diluted Net Income per Share was $0.16 and $0.13 for the three months ended March 31, 2019 and 2018, respectively.

Recently, First Acceptance announced that effective October 1, 2019, Mr. Larry Willeford, the Company's Chief Claims Officer, will be promoted to President and Chief Operating Officer and take on the leadership of day-to-day operations of First Acceptance. Mr. Willeford joined the Company in October 2016 as its Chief Claims Officer. He is a CPCU with greater than three decades property and casualty insurance experience. Mr. Willeford had most recently served as Vice President Claims for State Auto Insurance in Columbus, Ohio from 2010 to 2016.

First Acceptance Corporation (FACO), closed Wednesday's trading session at $0.95, off by 1.9102%, on 5,815 volume with 13 trades. The average volume for the last 3 months is 7,388 and the stock's 52-week low/high is $0.949999988/$1.50.

chart

Maverick Technology Solutions (MVRK)

Penny Stock Hub, OTC Markets, EuroInvestor, Investors Hangout, Global Banking and Finance, Stockwatch, TradingView, Stockhouse, Research Pool, News To Watch, Wallet Investor, and Globe Newswire reported earlier on Maverick Technology Solutions (MVRK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Maverick Technology Solutions is the manufacturer of the highly acclaimed ROSINBOMB™ line of extraction presses and technology. The ROSINBOMB™ line of rosin presses and accessories is for extracting organic concentrates. ROSINBOMB presses are manufactured to be the premier quality presses available. The elegant, stainless steel, fully electric and patent-pending technology delivers 5,000+ lbs of pressure designed to ensure the highest possible yield.

ROSINBOMB presses require no chemicals or additional hardware to operate. Moreover, the presses are plug and play out of the box. The technology uses patent pending techniques to optimize extraction potential and allow the user the ability to easily produce naturally extracted, organic concentrates.

Rosin is a solventless extraction made through the mechanical process of applying heat and pressure to "press" out the terpene and cannabinoid rich resin from cured flower or hemp. Because ROSINBOMB presses are plug-n-press, the process is very simple. It occurs almost instantaneously and requires virtually no professional expertise in the field of botanical extractions.

ROSINBOMB uses heat and pressure to liquify and press out the plant's essential oils. The resin rich sap will subsequently reconstitute on the parchment paper, ready for collection. Upon scraping the parchment paper, the waxy residue collected will be clean and ready to dab. Presently available ROSINBOMB™ products include the consumer targeted ROSINBOMB Rocket press and the commercially targeted ROSINBOMB M-50 press and related accessories.

Yesterday, Maverick Technology Solutions announced the recent patent filing of its pioneering Flow Channel Technology™. This technology enables processors to now produce large volumes of solventless extracts solely using heat and pressure. The frictionless Flow Channel Technology™ is a huge leap forward in extract production at a fraction of the cost of existing solvent-based systems.

Mr. Ryan Mayer, Inventor and President of Maverick Technology Solutions, said, “By advancing forward the existing technology that has propelled ROSINBOMB to become the leader in solventless extract production, we were able to develop our Flow Channel Technology™ to make solvent free mass production a reality. This combined with the added advantage of removing the use of parchment and eliminating manual collecting from the equation, undoubtedly delivers the industry the preeminent solution to manufacturing the highest quality clean extracts at an unparalleled cost.”

Maverick Technology Solutions (MVRK), closed Wednesday's trading session at $1.50, up 15.3846%, on 100 volume with 1 trade. The average volume for the last 3 months is 7,388 and the stock's 52-week low/high is $0.056000001/$2.0999999.

chart

Golden Arrow Resources Corp. (GARWF)

MarketWatch, GuruFocus, Junior Mining Network, Proactive Investors, Wallet Investor, Stockhouse, Streetwise Reports, Money and Markets, Equity Clock, InvestorsHub, FutureMoneyTrends, YCharts, Investor Intel and 24hgold reported earlier on Golden Arrow Resources Corp. (GARWF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Golden Arrow Resources Corp. is an explorer and prospect generator. The Company’s focus is identifying, acquiring, and advancing precious and base metal discoveries with the aim of defining first-class deposits. Its chief emphasis is on advancing its flagship Chinchillas Silver Project in Jujuy Province, Argentina. Golden Arrow Resources is headquartered in Vancouver, British Columbia and has exploration offices in Ciudad de Mendoza, Argentina.

The Company is exploring a new portfolio of advanced projects in Chile, as well as other targets within its portfolio of over 200,000 hectares of properties in Argentina. Golden Arrow Resources is a member of the Grosso Group; a management company specializing in resource exploration.

Golden Arrow’s other Argentina projects include the Antofalla Silver-Gold-Base Metal Project in Catamarca Province; and the Don Bosco Copper-Gold Project and the Caballos Copper-Gold Project, both in La Rioja Province. Projects additionally include the Mogote Copper-Gold Project; the Pescado Gold Project; and the Frontera District - Potrerillos Gold-Silver Project. All of these projects are in San Juan Province.

Golden Arrow Resources has established a 100 percent owned subsidiary named “New Golden Explorations, Inc.” New Golden Explorations has been focused on acquiring advanced stage exploration projects with the potential to deliver sizable added share value. New Golden Explorations previously announced the acquisition of the Indiana Gold-Copper and the Atlantida Copper-Gold projects.

The Chinchillas Silver deposit will be developed into a satellite open-pit mine. The Chinchillas Silver Project features low capital expenditure and fast-tracked development utilizing infrastructure from the Pirquitas mine. It has a positive pre-feasibility study with strong economics and immediate production income from the Pirquitas mine operation.

Golden Arrow Resources established a Joint Venture (JV) with Silver Standard Resources, Inc. The JV is called Puna Operations, Inc. (POI). POI is 75 percent owned and operated by Silver Standard and owned 25 percent by Golden Arrow Resources. It was created to hold the Chinchillas project and the Pirquitas project that consist of the San Miguel open pit mine, which ended mining operations in January 2017 (the Pirquitas Pit), and the associated mineral processing facilities and tailings facility (the Pirquitas Operation) in Argentina.

Golden Arrow Resources announced this past December that its JV partner in Puna Operations declared commercial production at the Chinchillas silver-zinc-lead mine as of December 1, 2018.

Recently, Golden Arrow Resources announced that it closed the second tranche of a non-brokered private placement via the issuance of 1,290,367 units at a subscription price of $0.30 per Unit for total gross proceeds to Golden Arrow of $387,110. Furthermore, because of continued robust demand, it increased the Unit offering to up to C$4.1 million in aggregate gross proceeds. All other terms of the financing will remain the same.

Golden Arrow Resources Corp. (GARWF), closed Wednesday's trading session at $0.1937, up 26.5186%, on 958,195 volume with 48 trades. The average volume for the last 3 months is 53,587 and the stock's 52-week low/high is $0.14/$0.424299985.

chart

Creative Medical Technology Holdings, Inc. (CELZ)

Live Trading News, MarketWatch, Emerging Growth, Stockhouse, Bio Quick News, Capital Cube, OTC Markets, InvestorsHub, Canadian Insider, and 4-Traders reported earlier on Creative Medical Technology Holdings, Inc. (CELZ), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Creative Medical Technology Holdings, Inc. (CMT) is a clinical stage stem cell company listed on the OTC Markets Group’s OTCQB. The Company’s focus is on Urology and Neurology using stem cell treatments. Since 2011, CMT and its affiliate company, Creative Medical Health, Inc., have concentrated on regenerative medical solutions for unmet Urological and Neurological needs.  The Company has a patent portfolio that encompasses all treatments.  CMT has its corporate office in Phoenix, Arizona.

The Company has formed CaverStem International LLC. This is a majority-owned subsidiary centered on commercializing stem cell therapy for erectile dysfunction to global physicians and their patients. CaverStem is offering the Caverstem™ technology to selected physicians in the United States that qualify according to CMT's criteria.

CMT has also established CerebroStem LLC. This majority-owned subsidiary focuses on developing stem cell therapies for brain injuries and neurodegenerative diseases. Its initial focus will be treating radiation induced brain damage.

Via its own research and collaborations with top academic institutions, CMT has acquired a pioneering stem cell (AmnioStem) and developed proprietary protocols. Moreover, the Company has built an extensive intellectual property (IP) portfolio, developed complete treatment offerings for erectile dysfunction (ED), and launched a 40-patient trial for ED at UCLA.  CMT is also making advances for treating stroke using its newly acquired amniotic fluid-based stem cell.  

AmnioStem is Amniotic fluid derived stem cell. The AmnioStem patent covers means to isolate, grow, and use amniotic fluid derived stem cells in a scalable and commercializable way. AmnioStem cells do not necessitate matching with the recipient, as one size fits all.

Recently, CMT  announced an update of its activities. Regarding CaverStem domestic activities, the Company is continuing marketing to physicians throughout the U.S. Additional physicians are scheduled for training, patients are being treated and revenues are being generated and growing each month. CMT anticipates reaching financial self-sufficiency by revenues from sales this year. 

Creative Medical Technology Holdings, Inc. (CELZ), closed Wednesday's trading session at $0.0045, up 28.5714%, on 16,845,072 volume with 141 trades. The average volume for the last 3 months is 10,638,110 and the stock's 52-week low/high is $0.0024/$0.057.

chart

Sports Field Holdings, Inc. (SFHI)

RedChip, Real Investment Advice, Investors Hub, Marketwired, Simply Wall St, The Street, Zacks, Market Screener, Stockhouse, Stockopedia, Barchart, Wallet Investor, Innovative Marketing, MarketWatch, and Marketbeat reported earlier on Sports Field Holdings, Inc. (SFHI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Sports Field Holdings, Inc. engages in the design, engineering, and construction of eco-safe athletic facilities. The Company, by way of its wholly-owned subsidiary, FIRSTFORM, Inc., is a product development, engineering and design-build construction business. Sports Field considers itself a leader in innovative playing surfaces that focus on player safety and high performance athletic fields. OTCQB-listed, Sports Field Holdings has its head office in St. Charles, Illinois.  

Sports Field engages in the design, engineering, construction, and construction management of athletic fields and sports complexes. In addition, the Company supplies its proprietary, technologically advanced, synthetic turf products and systems to the industry. Its two principal lines of business are construction management of sports facilities and synthetic turf sales. Sports Field says that these two lines of business can be categorized as design, development, and manufacturing of sports surfacing products and associated pre-engineered construction systems. 

The Company’s FIRSTFORM® subsidiary supplies its proprietary patent-pending products, athletic field systems, and knowledge-based services to the athletic construction industry.  For customers, a FIRSTFORM® Architect will customize their design plan. Additionally, a FIRSTFORM® Design Engineer will create their drainage plan. A FIRSTFORM® Project Manager will also manage the entire construction process. 

Sports Field Holdings has its "PrimePlay" crumb rubber-free line of synthetic turf products. The Company’s flagship PrimePlay™ products are available and undergoing installation in athletic facilities across the U.S.  Sports Field’s PrimePlay® Replicated Grass is crafted to closely mirror natural grass. It has a blade density almost three times greater than conventional artificial turf.

Sports Field also has its Primetrack Accel™ product line. This product features polyurethane derived from premium raw materials and secure traction and optimal slip protection. Primetrack Accel™ also features optimal force absorption, spike resistance, and is available in full range of color options. Primetrack Accel™ also features a uniform, consistent surface with durable performance.

Sports Field Holdings, Inc. (SFHI), closed Wednesday's trading session at $0.3028, up 95.4557%, on 100 volume with 1 trade. The average volume for the last 3 months is 1,508 and the stock's 52-week low/high is $0.129999995/$0.649999976.

chart

Adama Technologies Corporation (ADAC)

StreetInsider, InvestorsHub, OTC Markets, Morningstar, and Stockhouse reported on Adama Technologies Corporation (ADAC),  and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Adama Technologies Corporation is a Venture Capital Company listed on the OTCQB. It owns, operates, and invests in technology companies and also startups and expansion companies. The Company has a hands-on approach and works to develop the management and leaders around the corporate landscape to transform big ideas into game changing execution in the field. Adama Technologies has its corporate office in Henderson, Nevada.

Adama Technologies has exceptional access to equity lines of credit, equity funds, private investors, incubators, mentor partners and close ties with Fortune 100, 500 and 1000 companies who serve as exit strategies for many of Adama’s investments.

Adama Technologies’ portfolio companies include Alpine Industries and SafeGuard Pii. Its flagship investment is Alpine Industries located in Utah. Alpine specializes in machining and aerospace manufacturing.

This investment and acquisition launches Adama Technologies into the fast expanding field of aerospace technology. Furthermore, it positions Adama with the stability of being a defense contractor for the U.S. military.

Since its establishment in 1974, Alpine Industries has manufactured several hundred aerospace landing gear components and other spare parts.  It continues to work as a US government contractor.

Presently, Alpine holds more than 15 US Military contracts. Most of these contracts are with the US Air Force. Alpine Industries also manufactures parts for a number of private companies. These include parts for drilling components utilized in oil and water wells, roller-coasters, motorcycles, zip line parts, crash pads, as well as drilling carts.

SafeGuard Pii is an industry pioneer and top-tier Privacy Management Firm. It provides compliance solutions to companies across the United States.  In addition, SafeGuard Pii is the provider of a strong identity theft protection and restoration product.

The Company’s PII Defender program monitors internet black market sites, other internet trading sites where ID thieves buy and sell information, utility and phone records, public databases, criminal databases and DMV records, plus credit files for one’s personal information.

Recently, Adama Technologies announced that it was accepted and successfully up-listed to the OTCQB marketplace with OTC Markets. Adama had outlined a course towards growth and development. This path included development of additional revenue streams, growing revenues within their present operations, and up-listing into the QB Marketplace.

In addition, Adama Technologies recently announced that the Company will bid on an additional $3,000,000 in new government contracts with at least $2,000,000 of that number being for US Military Defense contracts.  Adama detailed its month-of-March bidding plan and strategy and its optimism concerning its ability to win these contracts. As the bidding process is underway, Adama Technologies will continue to look for additional revenue opportunities in its commercial and retail outlets.

Adama Technologies Corporation (ADAC), closed Wednesday's trading session at $0.0028, up 115.3846%, on 32,500 volume with 5 trades. The average volume for the last 3 months is 121,412 and the stock's 52-week low/high is $0.009999999/$0.180000007.

chart

StartMonday Technology Corp. (STMDF)

Dividend Investor, OTC Markets, Stockhouse, MarketWatch, Barchart, GuruFocus, Science of Stocks, Investorx.ca, and Penny Stock Hub reported on StartMonday Technology Corp. (STMDF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

StartMonday Technology Corp. engages in candidate selection solutions for employers in the retail and hospitality sectors. The Company helps employers choose better candidates, quicker, with the power of 15-second video introductions. A smart recruitment technology enterprise, StartMonday Technology has its corporate headquarters in Vancouver, British Columbia. The Company’s shares trade on the OTC Markets Group’s OTCQB.

StartMonday Technology was founded by professionals from the recruiting and tech fields - Ray Gibson from recruiting and HR, and Andrew Evans from the founding team at Careerbuilder.com.

StartMonday Technology’s commitment is to building strong tools for the Mobile Generation. Moreover, the Company is further developing its technology with an open blockchain solution for verifiable career histories named CareerChain.

StartMonday's video-led mobile and web applications deliver a better impression of customer skills and personality, ultimately assisting employers in deciding which candidates they should talk to first. This makes the process much more efficient.

StartMonday's core products center around 15-second videos filmed by candidates on their own mobile phones and web browsers. This puts job applications decisively in the social media and mobile native arena.

This enables job seekers to present themselves in their own way. In addition to lessening cost and time-to-hire, the Company brings massive employer branding opportunities to its clients.

Recently, StartMonday Technology announced that it has partnered with Talent Tech Labs (TTL)- Manhattan-based, as part of their late-stage accelerator program targeted at advancing select, mature startups ready for targeted penetration into the North American market. Talent Tech Labs is a sector leader in the knowledge and analysis of up-and-coming trends and technologies applied to improving the state of the art of recruitment.

StartMonday Co-Founder and Chief Executive Officer, Mr. Ray Gibson said, “We are extremely pleased to have been selected for the TTL accelerator program. This is a limited and very influential opportunity that has previously proven its worth at propelling entry into the U.S. marketplace… We believe this program will ideally position us to really show what StartMonday and CareerChain can do to accelerate success within the HR industry arm of Corporate America.”

StartMonday Technology Corp. (STMDF), closed Wednesday's trading session at $0.04, up 426.3158%, on 4,000 volume with 1 trade. The average volume for the last 3 months is 541 and the stock's 52-week low/high is $0.0076/$0.081200003.

chart

HD View 360, Inc. (HDVW)

OTC Markets, MarketWatch, TradingView, and MarketNewsUpdates reported on HD View 360, Inc. (HDVW), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A full-service Information Technology (IT) company, HD View 360, Inc. and its subsidiary companies are a complete Business-to-Business (B2B) Information Technology solution. The Company provides hardware installation, security monitoring systems, telephone services, merchant processing, Point-of-Sale (POS) software, and continuing IT support to small and medium-sized businesses (SMBs). HD View 360 is headquartered in Miami, Florida.

The Company has practical experience in almost every aspect of retail operations. One of HD View 360’s wholly-owned subsidiaries is SimpleFone. This subsidiary is an innovative Voice over Internet Protocol (VoIP) provider. At present, SimpleFone is selling its telephone services to numerous nationally-recognized franchise brands. HD View 360 is positioning SimpleFone to become a foremost VoIP carrier.

SimpleFone has secured a data housing center close to its headquarters in Miami, with a redundancy center in Phoenix, Arizona. It also purchased a new VoIP phone switch that can service up to 100,000 phone lines at the same time.

Recently, SimpleFone has been overhauling its infrastructure to prepare for an influx in growth by launching a more consumer-driven website, introducing its Simple Affiliate Partner sales program, implementing new software and POS/CRM integration functionality, and creating a much safer and secure SRTP/TLS compliant encryption platform. By way of these upgrades, and more, SimpleFone’s plan is to further support its increasing list of consumer and investor needs.

HD View 360 and Voice Solutions, Inc. announced last month a new strategic partnership. This partnership will take advantage of access to enterprise-level customers and create mutual avenues of recurring revenue streams for both businesses. 

Voice Solutions is one of the top providers of in-store music, on-hold message services, digital signage, sound masking, and other impactful sensory marketing services. Voice Solutions is the first member of HD View 360’s Simple Affiliate Partner Program.

HD View 360 recently announced the launched of development of its proprietary POS Software via its wholly-owned subsidiary, HD View Technologies. The specific design of this POS solution is with the franchise and multi-location retail segment in mind.

The Company’s POS solution will seamlessly integrate its client's businesses, products, customers, and payment systems into one user-friendly platform. The next generation POS software will take advantage of HD View 360's merchant processing service and its years of experience working with franchise brands to provide clients with a complete and specialized retail solution.

Recently, HD View 360 announced that subsidiary HD View Technologies signed its first Letter of Intent (LOI) with Pizzafire. This is to supply its POS technology to all locales across the country. The next generation POS will enable the growing restaurant chain to more efficiently staff, save time on menu updates, as well as keep closer tabs on new locations.

Of note is that 19 Pizzafires are open, 15 more are planned by the end of 2017, and there are numerous POS systems per location. HD View 360’s anticipation is that this contract will be a considerable revenue generator in the months ahead.

HD View 360, Inc. (HDVW), closed Wednesday's trading session at $0.0004, up 33.3333%, on 100 volume with 1 trade. The average volume for the last 3 months is 146 and the stock's 52-week low/high is $0.25/$5.65000009.

chart

American Power Group Corp. (APGI)

OTCBB Journal, TaglichBrothers, and SmallCapVoice reported earlier on American Power Group Corp. (APGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

American Power Group Corp. designs and produces proven alternative fuel solutions for stationary power generators, backup power systems, and commercial transportation. The Company’s alternative energy subsidiary, American Power Group, Inc. (APG), provides a cost-effective patented Turbocharged Natural Gas® Dual Fuel Conversion Technology for vehicular, stationary, as well as off-road mobile diesel engines. American Power Group is headquartered in Lynnfield, Massachusetts and lists on the OTC Markets Group’s OTCQB.

The Company’s patented Turbocharged Natural Gas® Dual Fuel Conversion Technology is a unique non-invasive software driven solution. It converts existing vehicular and stationary diesel engines to run simultaneously on diesel and different kinds of natural gas. This includes compressed natural gas, liquefied natural gas, conditioned well-head/ditch gas or bio-methane gas with the flexibility to return to 100 percent diesel fuel operation at any time.  It is a ground-breaking non-invasive energy enhancement system.

American Power Group (with its proprietary Flare to Fuel™ process technology) can convert captured gases into natural gas liquids (NGLs) that can sell as heating fluids, emulsifiers, or be further processed by refiners. Via the Company’s Trident Associated Gas Capture and Recovery Technology, it can provide oil and gas producers a flare capture service solution for associated gases produced at their remote and stranded well sites.  

Regarding American Power Group’s dual fuel, methane gas is metered into a diesel engine's air intake, before the turbocharger, by the air filter. As the enriched air/gas mixture increases the engine's power, the diesel's own governor senses the power increase and backs off on diesel flow. The system maintains a balance of gas-to-diesel ratios.

The maintaining of the energized fuel balance is with a proprietary read-only electronic controller system. This ensures the engines operate at original equipment manufacturers' (OEMs) specified temperatures and pressures. Installation on a broad collection of engine models and end-market applications demands no engine modifications.

Recently, American Power Group announced that it will extend the filing of its June 30, 2017 Quarterly Form 10Q through SEC Form 12b-25.  The Company announced on June 6, 2017, a corporate wide realignment of its strategic direction, reallocation of resources, and reduction in workforce in response to considerable operating losses because of the effect that ongoing low oil prices were having on its dual fuel and flare capture businesses. The realignment resulted in a decrease in annual operating costs of greater than $2 million on a going forward basis.

American Power Group Corp. (APGI), closed Wednesday's trading session at $0.02, up 98.0198%, on 5,700 volume with 2 trades. The average volume for the last 3 months is 12,759 and the stock's 52-week low/high is $0.002899999/$0.137500002.

chart

The QualityStocks Company Corner

ORHub Inc. (ORHB)

The QualityStocks Daily Newsletter would like to spotlight ORHub Inc. (ORHB).

ORHub Inc. (ORHB) is a growth-stage data analytics company on a mission to optimize the business of surgery through lean process improvement. As a Microsoft Silver Partner, ORHub leverages the Azure cloud to help customers unlock the power of data captured in the operating room by surfacing key business indicators into a curated set of dynamic dashboards.

ORHub’s Surgical Spotlight® is a cloud-based analytics tool that helps administrators, nurse leaders and surgeons make improved business decisions for the operating room. By taking data feeds from the facility’s Operating Room Information System, ORHub produces a functional and elegant dashboard that allows users to easily identify opportunities for improvement.

These capabilities allow providers to harness data, identify millions of dollars in opportunities, and get leaders back to their primary focus of improving care, increasing patient access and reducing costs. A first-of-kind team building tool brings all stakeholders together with regular and accessible information. ORHub specializes in business intelligence for the operating room, built by professionals with experience in the operating room.

Surgical Spotlight video featuring renowned cardiac surgeon and ORHub Chief Medical Officer Dr. Robert (“Bobby”) Lazzara

 

Partnerships

ORHub is proud to partner with top tier facilities and organizations, including:

  • Hoag Orthopedic Institute & Hoag Memorial Hospital in the Providence network
  • Baptist Health, Jacksonville
  • Alvarado Hospital Medical Center in the Prime network
  • Orthopedic Institute Surgery Center in the SMP network
  • Metropolitan Surgery Center in the USPI network
  • Anderson Regional Medical Center

ORHub has attended and presented at several events in 2019, also gaining approval to present Surgical Spotlight® at nursing forums and offer 1.2 contact hours toward Continuing Education Units (CEU) from Terri Goodman, RN, PhD, & Associates, an approved provider by the California Board of Registered Nursing (provider number CEP 16550).

Industry Statistics

The U.S. surgical market continues to grow, with over 5,500 hospitals and 6,100 ambulatory surgery centers (ASCs) performing over 50 million medical procedures annually. According to MarketsandMarkets, the global health care analytics market will approach $50 billion by 2024 with a five-year Compound Annual Growth Rate (“CAGR”) of 28.3% from 2019.

Management Team

Chief Executive Officer Colt Melby has over 30 years of experience in both public and private companies as a senior level executive. He is an active entrepreneur and investor who focuses on high-growth companies.

Chief Financial Officer Barney Monte has more than 20 years of global investment banking and capital markets experience. He has worked with numerous growth stage companies.

Chief Medical Officer Dr. Robert “Bobby” Lazzara is a distinguished cardiac surgeon, a medical media expert, and founder of Medical News Minute. He performed the first worldwide webcast of open-heart surgery in August 1998 through the Virtual Operating Room and is a Smithsonian Laureate for his pioneering work utilizing the internet and information technology as a health care educational tool. Dr. Lazzara has been a member of advisory boards and a consultant to major corporations and medical device companies.

Investor Relations
Jason Brown
Jason.Brown@ORHub.com
(714) 228-5667

ORHub Inc. (ORHB), closed the day's trading session at $0.08, up 3.36%, on 64,017 volume with 8 trades. The average volume for the last 3 months is 128,734 and the stock's 52-week low/high is $0.021/$0.85.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) (the “Company” or “PLUS”) today announced a new look for its line of low dose cannabis infused edibles. The rebrand was guided by market structure research from Henry J. Rak Associates and designed by Partners & Spade, an agency that has worked alongside brands including Peloton and Warby Parker.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Wednesday's trading session at $2.724, up 3.9536%, on 57,069 volume with 50 trades. The average volume for the last 3 months is 63,789 and the stock's 52-week low/high is $2.51999998/$6.00810003.

Recent News

chart

Green Hygienics Holdings Inc. (GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Green Hygienics Holdings (OTCQB: GRYN), a full-scope, science-driven, premium-cannabis cultivation and branding enterprise, is poised to capitalize in the growing California hemp market as new industrial hemp regulations establish registration procedures for cultivators in the state (http://nnw.fm/2UlCn). To view the full article, visit: http://nnw.fm/pF7Ri.

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.

The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.

Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.

Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.

Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.

The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.

Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.

Green Hygienics Holdings Inc. (GRYN), closed Wednesday's trading session at $1.47, up 2.7972%, on 11,385 volume with 12 trades. The average volume for the last 3 months is 17,545 and the stock's 52-week low/high is $0.100100003/$1.80999994.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

The Supreme Cannabis Company, Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced that it has entered into a definitive agreement (the "Acquisition Agreement") under which Supreme Cannabis will acquire all of the issued and outstanding shares of privately-held Truverra Inc. ("Truverra"), to be effected by way of a three-cornered amalgamation between Truverra, Supreme Cannabis and a wholly-owned subsidiary of Supreme Cannabis (the "Transaction"). Also today, NetworkNewsWire released a report on the company detailing how, in partnership with Khalifa Kush Enterprises Canada, the company is debuting a new line of cannabis oils named KKE Oils. The offering is the first in a suite of new products from the partnership, the companies jointly announced (http://nnw.fm/nyAq6).

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Wednesday's trading session at $1.1695, up 9.2991%, on 661,681 volume with 772 trades. The average volume for the last 3 months is 312,179 and the stock's 52-week low/high is $0.850000023/$2.03999996.

Recent News

chart

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)

The QualityStocks Daily Newsletter would like to spotlight Siyata Mobile Inc. (SYATF).

Global developer and provider of cellular communications systems Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF) today announced its receipt of a $700,000 purchase order from a single end-use customer. According to the update, the order is to equip the customer’s mobile workforce and vehicle assets with UR7 rugged handsets and CP250 in-vehicle device for a national railway company. To view the full press release, visit: http://nnw.fm/Mg1b2.

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of Push-to-Talk Over Cellular ("PTT/PoC") systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.

Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.

Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.

The company has long been an industry pioneer, delivering the world's first 3G connected vehicle device as well as the world's first 4G/LTE vehicle mounted smartphone for First Responders and commercial fleets and vehicles.

Siyata is headquartered in Montréal, Québec, Canada.

Product Portfolio

Siyata's suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.

The company's flagship product, the Uniden UV350, is the world's first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.

The Uniden UV350 is currently available through Bell Mobility, Canada's largest LTE network and PTT community. Expanding its availability, Siyata is completing network approval with two North American Tier 1 operators to launch the UV350 in the U.S. in 2019.

Management Team

CEO and Chairman Marc Seelenfreund is the founder of Siyata. He is also the founder of Siyata's parent company, Accel Telecom, an Israel-based company that specializes in importing and distributing innovative cellular and IP devices to fixed line operators and mobile providers within Israel. Prior to establishing Accel, Seelenfreund was a vice president at Sunrise Corporation in New York where he focused on financing publicly traded technology companies. Seelenfreund has a law degree from Bar Ilan University, is a board member at Israel's leading private university, and has served as an officer in the Israel Defense Forces.

Glenn Kennedy, vice president of sales, has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Kennedy managed sales nationally for Motorola Canada, HTC Communications Canada, and Sonim Technologies. He holds a bachelor's degree in honors business administration from the Richard Ivey School of Business at the University of Western Ontario.

CFO Gerald Bernstein, a professional chartered accountant, has spent 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. He holds a bachelor's degree of commerce as well as a graduate diploma in public accountancy from McGill University. Bernstein has been a member of the Canadian Institute of Chartered Accountants since 1987.

Gidi Bracha, Vice President of Technology, has served in this position since 2011 and spearheaded the development of both the Truckfone, Voyager and UV350. Bracha served in various key positions at Cellcom, Israel's leading cellular provider, including head of car mobility products and director of type approvals. Bracha served as an engineer technician in the Anti-Aircraft division of the Air Force in the Israel Defense Forces and holds a bachelor's degree in engineering and business management from the University of Derby.

Siyata Mobile Inc. (SYATF), closed Wednesday's trading session at $0.3782, up 1.1771%, on 112,750 volume with 20 trades. The average volume for the last 3 months is 60,955 and the stock's 52-week low/high is $0.288599997/$0.446249991.

Recent News

chart

Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF).

Choom™ (CSE: CHOO; OTCQB: CHOOF), is pleased to announce that, pursuant a convertible debenture issued to Choom by Coastal Green Holdings Ltd., Choom will, on conversion of the debenture, acquire a 19.9% equity interest in Coastal Green. Also today, CannabisNewsWire released a report featuring the company, which examines the recent news that the Department of Health in New Jersey announced that interested parties could start submitting their applications to grow and sell marijuana. Both nonprofit and for-profit entities are eligible to apply during this round of licensing. Furthermore, was featured today in the 420 with CNW by CannabisNewsWire. Recent cannabis industry retail sales revenues are projected by Marijuana Business Daily’s annual Marijuana Business Factbook to triple to $30 billion by 2023. If these numbers are not enough to excite you (which they should!) according to a Bank of America analyst, the cannabis industry could one day offer peak annual sales potential of $166 billion and disrupt industries that currently total $2.6 trillion in yearly sales.

Choom Holdings Inc. (OTC: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.

Choom Holdings Inc. (CHOOF), closed Wednesday's trading session at $0.32, up 4.0989%, on 220,214 volume with 114 trades. The average volume for the last 3 months is 252,587 and the stock's 52-week low/high is $0.284999996/$1.01540005.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade Inc. (OTC:SGMD) today announces its placement in an editorial published by CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company for private and public entities in the cannabis industry. To view the full publication, titled “With 10,000 Licenses Issued, California Reflects the Growing Power of Hemp,” please visit: http://cnw.fm/Ru1jl.

Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6

Sugarmade, Inc. (SGMD), closed Wednesday's trading session at $0.0159, up 6.7114%, on 6,201,940 volume with 160 trades. The average volume for the last 3 months is 2,584,485 and the stock's 52-week low/high is $0.0142/$0.197500005.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences Inc. (PBIO) was featured today in a report by NetworkNewsWire. Foodborne illnesses are a costly, common public health problem. Researchers have identified more than 250 foodborne diseases, with 48 million people a year falling ill after consuming contaminated foods or beverages, according to the U.S. Centers for Disease Control and Prevention (http://nnw.fm/Rhd2I). Of those who get sick, 128,000 are hospitalized, and 3,000 die. “Do I have food poisoning?” is a very common expression and one of the first thoughts people express when they worry about whether they’ve been infected by a foodborne infection.

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed Wednesday's trading session at $3.19, up 1.5924%, on 6,022 volume with 20 trades. The average volume for the last 3 months is 9,045 and the stock's 52-week low/high is $1.51999998/$4.0999999.

Recent News

chart

Hemptown USA

The QualityStocks Daily Newsletter would like to spotlight Hemptown USA.

Legislative changes in the U.S. and other parts of the world, as well as changing consumer attitudes, are contributing to the rapid expansion of the hemp products market. The industrial hemp market is anticipated to grow at a CAGR of 18.3 percent through 2027 (http://ibn.fm/Hstkn). Market research indicates that the CBD segment is the one that will grow the most, with some forecasts suggesting that that the CBD product market could reach $20 billion by 2024 (http://ibn.fm/4xDh6). Combined with THC products, this market is on course to reach more than $45 billion by 2024. Such lucrative forecasts are contributing to the establishment of numerous producers and CBD companies. To be successful, however, these enterprises need some competitive advantage. One of the biggest strengths in the future will come from an ability to maximize hemp yields and bring down production costs. Companies like Hemptown USA are changing hemp cultivation through technology to keep production costs low and optimize yields.

Hemptown USA, headquartered in Central Point, Oregon, is a proven grower of full-spectrum hemp biomass grown using premium seed genetics that contain less than 0.3% THC and exceptionally high cannabinoid (CBD) content of up to 20%. The company's "soil to oil" methodology combines seasoned professionals working in hand-picked agricultural microclimates located in Oregon's famed Emerald Triangle, Kentucky and Colorado.

Hemptown has exclusive rights to 1 million rare CBG (cannabigerol) seeds genetically programmed to yield from 15% to 20% full-spectrum non-intoxicating cannabinoids. As a result of a long-standing relationship with the one of the world's most respected cannabis breeding companies – Oregon CBD Seeds – Hemptown is positioned to be a leading CBG producer in the U.S. in 2019 and beyond.

In 2018 Hemptown's harvest from its Oregon hemp farm was 150,000 pounds of full-spectrum biomass with CBD content hovering around 17%. 2018 harvest revenue expected to range from $8.1 million to $12.6 million. The company is scaling up operations in 2019 to meet market demands and projects it will reap over 1,000,000 pounds. By 2020, Hemptown projects potential revenues in the $100 million to $200 million range are possible once additional farming operations are at full strength.

Growth Strategy

By 2020, Hemptown anticipates it will have more than 3,000 acres in several states dedicated to hemp farming. Expansion plans include increasing in-house extraction capabilities to boost profit margins by providing additional CBD and CBG isolates and distillation services. Development of business-to-business channels as well as new products and formulations for the direct-to-consumer market, along with several strategic acquisitions, are also key to Hemptown's growth strategy.

Hemptown plans to expand distribution and growing operations globally through strategic partnerships and development of contracts with leading Fortune 500 brands in European markets. The company intends to grow its IP portfolio by developing a proprietary water-soluble cannabinoid delivery system. Not to be confused with water-compatibility, water-soluble cannabinoids combine seamlessly with other liquids, have a superior shelf life, and deliver dramatically increased efficacy to the consumer.

Branded Products

Hemptown's first in-house branded product line combines the inspiring strength found in the unbridled nature that surrounds the company's original hemp farm in the Siskiyou Klamath region of Oregon. Sisku is set to redefine the cannabinoid packaged goods space with an elegant look, clean feel and potent, reliable efficacy.

Custom product lines can also be created for any product manufacturer as Hemptown brings GMP and ISO accredited processing facilities online in 2019. Together with Oregon CBD Seeds and Hemptown's product sciences team, Hemptown will be able to create custom, proprietary full-spectrum CBD and CBG oils and pure isolates.

Management Team

Company Chairman Rod Wolterman founded Hemptown's Oregon operations in 2016. He has extensive experience in the cannabis sector having been active within the space since 1998. Wolterman has also acted as a private equity investor in numerous medical marijuana dispensaries and cultivation operations in southern California.

CEO John Cummings has over 20 years of experience in finance, marketing, sales and project management. He led the compliance and special projects efforts for Kings Garden, one of the largest vertically integrated operators in California. Cummings also spent a year in Europe launching the continent's first GMP and ISO-accredited cultivation and manufacturing facility.

Dr. Gordon Chiu is chief science officer for Hemptown USA. He has more than 15 years of combined domestic and international experience in biomedical, chemical, cosmetic, medical and technology industries. A graduate of Rensselaer Polytechnic Institute with a master's degree from Seton Hall University, Chiu is leading Hemptown's cannabinoid research team and is responsible for filing IP patents, specifically in the areas of water-solubility, bioavailability and peptide sequencing.


Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Florida-based biotechnology company Earth Science Tech (OTCQB: ETST), through its wholly owned subsidiaries, is focused on establishing its role as a global leader in the CBD space. To view the full article, visit: http://nnw.fm/X21iu.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed Wednesday's trading session at $0.75, even for the day, on 20,190 volume with 18 trades. The average volume for the last 3 months is 57,243 and the stock's 52-week low/high is $0.300999999/$2.45000004.

Recent News

chart

INmune Bio Inc. (NASDAQ: INMB)

The QualityStocks Daily Newsletter would like to spotlight INmune Bio Inc. (NASDAQ: INMB).

Could tumor necrosis factor-alpha (TNF-α) inhibition be the next big thing in the world of Alzheimer’s disease (AD) treatment? A detailed Washington Post report focuses on research carried out by a Pfizer Inc. (NYSE: PFE) team (http://nnw.fm/3R9va). According to the researchers, one of the company’s rheumatoid arthritis anti-inflammatory drugs appeared to reduce the risk of Alzheimer’s disease development by as much as 64 percent. Several pre-clinical studies have shown a connection between inflammation and Alzheimer’s disease pathology. In one of these trials, XPro1595 by INmune Bio Inc. (NASDAQ: INMB) prevented the accumulation of C-terminal amyloid beta protein. The conclusion reached was that the inhibition of soluble TNF signaling prevents pre-plaque amyloid-associated neuropathology, a risk factor implicated for its link to AD.

INmune Bio Inc. (NASDAQ: INMB) is a diversified clinical-stage immunology company developing novel therapies that target distinct parts of a patient's innate immune system to fight disease. Drug candidates INKmune™ and INB03 may be used to treat cancer while XPro1595 targets neuroinflammation as a cause of Alzheimer's disease. INmune Bio's product platforms utilize a precision therapy approach to promote the body's innate immune response to treat unsolved problems in medicine.

INmune Bio is the first biotechnology company to close an initial public offering (IPO) in 2019 and commence trading on The Nasdaq Capital Market. The company also received a "Part the Cloud" award from the Alzheimer's Association in 2018 which included a $1 million grant to advance INmune Bio's XPro1595 drug candidate.

INmune Bio's product pipeline targets three segments of concern:

  • Alzheimer's disease/dementia claims 5.5 million patients in the United States. INmune Bio views Alzheimer's as an immunologic disease which changes the drug discovery process, changes the way clinical trials are designed, and may provide hope for patients and caregivers.
  • Cancer residual disease which is expected to generate more than 1.7 million new cases yearly with an estimated 609,640 fatalities. INMB believe that converting resting Natural Killer ("NK") cells to primed NK cells, which kill cancerous cells on contact, is an important therapeutic strategy to help clear residual disease.
  • Resistance to immunotherapy. By preventing the proliferation and function of cells that resist immunotherapy, patients should have a stronger immune response to cancer cells and may respond better to other cancer treatments including immunotherapy and live longer.

INmune Bio Drug Candidates and Clinical Programs

INKmune is a biologic delivery system that primes a patient's resting NK cells to kill cancer. INKmune targets residual disease for patients that have completed initial cancer therapy (surgery, radiation and/or chemotherapy) and have a low burden of disease with a high risk of relapse.

In late 2019, INKmune will start enrolling patients in a phase I/II trial for women with relapsed refractory ovarian cancer. In many patients, cancer relapse after seemingly effective cancer therapy is due to a failure of the patients own NK cells to eliminate minimal residual disease ("MRD").

Using a novel mechanism of action and a precision medicine approach, INKmune therapy should enhance NK cells' ability to eliminate residual disease.

INB03 is a checkpoint inhibitor that targets myeloid derived suppressor cells ("MDSC") which can produce an immunosuppressive shield that prevents a patient's own immune system from attacking the cancer. INmune Bio is currently completing a monotherapy INB03 phase I trial in patients with advanced solid tumors. The INB03 program will transition into a combination therapy clinical program in the summer of 2019 to prepare for a phase II trial in patients resistant to checkpoint inhibitors due to increased MDSC.

Treatment with INB03 should eliminate MDSC in the tumor microenvironment to allow checkpoint inhibitors to be therapeutically effective.

XPro1595 targets the microglial immune cells of the brain that are activated in many Alzheimer's disease patients. These microglial cells are a cause of neuroinflammation that can kill nerve cells and promote synaptic dysfunction – the cause of dementia in Alzheimer's.

The three-month, phase I trial is expected to enroll 18 patients in summer of 2019. It is designed to measure traditional and novel biomarkers of inflammation in patients with mild to moderate Alzheimer's disease who have neuroinflammation. The trial is supported by a $1 million "Part the Cloud" grant from the Alzheimer's Association. Inflammation, especially chronic inflammation, is being recognized as an important part of the pathology of many diseases including cancer and Alzheimer's disease.

Management

Dr. RJ Tesi, M.D., INmune Bio co-founder, CEO and acting chief medical officer, has been a licensed physician since 1982 and a Fellow of the American College of Surgery since 1991. He received his medical degree from Washington University School of Medicine in 1982 and has served many roles in several development-stage biotech companies focused on treatment of neurodegenerative diseases, hematologic malignancies, and other inflammatory diseases.

CFO David J. Moss co-founder, has been with the company since its formation in September 2015. He holds an MBA from Rice University and a bachelor's degree in economics from the University of California, San Diego. Moss has founded, funded and taken public various companies in a variety of industries since 1995.

Mark Lowdell, Ph.D. co-founder, has served as the chief scientific officer and chief manufacturing officer at INmune Bio since the company's formation. He is a professor of cell and tissue therapy at University College London where he has led a translational immunotherapy group since 1994. He has also been a director of cellular therapy at the Royal Free London NHS Foundation Trust. He received his Ph.D. in clinical immunology from London Hospital Medical College, University of London in 1992 and is a qualified immunopathologist.

Christopher J. Barnum is director of neuroscience at INmune Bio. Barnum is a neuroimmunologist with broad expertise across neurodegenerative and psychiatric diseases holding multiple positions in academic and industry. His focus has been on translating inflammatory therapies into clinical treatments for neurologic diseases using a biomarker-directed approach. Barnum's research has been supported by the NIH, the Michael J. Fox Foundation, and the Alzheimer's Association. He received his Ph.D. in neuroscience from Binghamton University.

INmune Bio Inc. (OTC: INMB), closed Wednesday's trading session at $9.09, off by 4.3158%, on 7,382 volume with 37 trades. The average volume for the last 3 months is 13,369 and the stock's 52-week low/high is $7.00/$11.50.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands (CSE:GGB) (OTC:GGBXF) today announces its placement in an editorial published by CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company for private and public entities in the cannabis industry. To view the full publication, titled “Waves of CBD Beauty Products Filling Shelves of Major Retailers Across the US,” please visit: http://cnw.fm/6vjFQ.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed Wednesday's trading session at $2.0273, off by 0.16743%, on 295,388 volume with 479 trades. The average volume for the last 3 months is 399,952 and the stock's 52-week low/high is $1.8068/$5.20499992.

Recent News

chart

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Petroteq Energy (TSX.V: PQE) (OTC: PQEFF), an oil and gas industry technology innovator that developed Clean Oil Recovery Technology (“CORT”) for surface tar-sands oil extraction, recently entered into a nonexclusive technology licensing agreement with Valkor LLC. To view the full article, visit: http://nnw.fm/uAL9A.

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil sands exploration and production on mineral leases in Vernal, Utah, and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 2,500-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Clean Oil Recovery Technology (CORT) System.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ. PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy Chairman Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry.

“API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy Inc. (PQEFF), closed Wednesday's trading session at $0.18, off by 7.3598%, on 162,481 volume with 63 trades. The average volume for the last 3 months is 263,580 and the stock's 52-week low/high is $0.169740006/$1.42999994.

Recent News

chart

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)

The QualityStocks Daily Newsletter would like to spotlight Pacific Rim Cobalt Corp. (OTCQB: PCRCF).

Pacific Rim Cobalt (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) this morning released an update letter from the company’s president and CEO Ranjeet Sundher. Per the update, the company is presently working to advance its 100% controlled Cyclops laterite nickel-cobalt project in Indonesia. To view the full press release, visit: http://nnw.fm/Xk6jG. Also today, the company was highlighted in a publication from Financialnewsmedia.com, examining how cobalt is in demand and the global Cobalt community is worried about future supplies… which means companies and countries will be looking for as of yet undiscovered sources. With so many uses the development of a more consistent supply chain is of great importance to countries around the world. Sciencing on its website says the US government treats cobalt as a strategic metal because a shortage would affect the economy, industry and defense of the country.

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is a Canada-based exploration company focused on the acquisition and development of production-grade cobalt deposits, a key raw material input for the growing lithium-ion battery industry.

Pacific Rim Cobalt and its Cyclops Nickel-Cobalt Project, located in the Depapre District, Jayapura Regency, Papua Province, Republic of Indonesia, is uniquely positioned in a region with potentially the largest source of cobalt outside of Africa. Strategically located near China, the world’s largest cobalt buyer, the Cyclops Project is a laterite (iron-hosted) mineral prospect, rich in cobalt and nickel. Cobalt consumption in China is on-track to use over 8,000 tonnes of cobalt annually by 2021 for electric vehicle production alone and is projected to remain the world’s largest cobalt consumer for many years to come.

Global demand for renewable power is fueling a massive shift from traditional energy supply chain economics to cobalt-reliant lithium-ion batteries, the world’s most widely used power source for portable applications such as electric vehicles and other high-tech applications.

Pacific Rim Cobalt management has concluded that strategic access to major markets offers the most important factor to servicing the rising demand for cobalt. The company’s acquisition of its initial asset in Indonesia offers near surface, strong nickel-cobalt mineralization in an area with excellent infrastructure including a nearby workforce, supplies, sealed roads, ocean access, nearby port facility and gentle topography. The project area, nestled on the north coast of Papua, Indonesia, establishes Pacific Rim Cobalt well within the economically attractive ocean-going transportation range to Asia and its lucrative, growing industrial markets.

Exploration efforts are currently focused on establishing a maiden compliant resource for the Cyclops project, both in historically identified and drill-tested prospects as well as previously unexplored areas of the claims. During the first nine months of 2018, the company focused on assembling the necessary agreements to access northern areas of the project hosting historically identified mineralized zones. Mapping, sampling and a mini-bulk sample within the mineralized zones has been completed, along with a small-scale program in the previously unexplored far southern area of the project. With surface access to priority targets now established, Pacific Rim Cobalt will initiate drilling and extract additional mini-bulk samples for further metallurgical testing.

“We are excited and optimistic about the unique possibility of developing this project into an asset that will add shareholder value and position the company to play a future role in the battery metals supply chain,” Pacific Rim Cobalt CEO Ranjeet Sundher recently stated (http://nnw.fm/u1HNs). “We expect the near-surface nature of cobalt/nickel mineralization at the Cyclops project will lend itself well to low-cost, logistically straightforward drilling. We thus anticipate the opportunity to undertake a resource calculation study, as well as ongoing metallurgy and process option testing, will present itself in the near future. It’s going to be a busy year ahead, and we look forward to getting the drills turning and building value.”

Pacific Rim Cobalt’s world-class management team includes Sundher, who has over 20 years of capital markets experience. Sundher is also president of Canrim Ventures Ltd., a Singaporean advisory firm specializing in early stage project finance and structure. He previously founded Indogold Exploration, a Jakarta-based mining service firm, and has raised over $40 million for companies in which he was a founder/partner.

Chief Financial Officer Steve Vanry has 25 years of professional experience in senior management positions with public and private natural resources companies, providing expertise in capital markets corporate finance, mergers and acquisitions, regulatory compliance, accounting and financial reporting.

Andre Talaska serves as country manager and technical supervisor. He has over 30 years of experience in the mining and exploration industry and has held senior positions with several companies in Australia and southeast Asia. Shakir Juffry, business development/engineering, is a chemical engineer and extractive metallurgist by background training who has over 20 years of experience in the Indonesian mining and minerals exploration field. Toto Suarto Sajali, operation and development manager, is a mining engineer with over 15 years of experience in Indonesian project assessment, development and operations.

Pacific Rim Cobalt Corp. (OTCQB: PCRCF), closed Wednesday's trading session at $0.097, off by 3.00%, on 32,832 volume with 17 trades. The average volume for the last 3 months is 16,589 and the stock's 52-week low/high is $0.070100001/$0.283899992.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.